department of otolaryngology Archives
Jan. 9, 2020—VUMC is testing an optimized cochlear implant delivery model that offers patients hearing tests, radiologic scans, surgical consultation, device selection and outpatient surgery all on the day of their initial visit.
Dec. 6, 2019—Two Vanderbilt University Medical Center physicians were recently inducted into Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum (CORLAS), an international otolaryngology society created to facilitate collaboration and the open sharing of discoveries and ideas.
Nov. 21, 2019—Jane Wilkerson Yount, a longtime supporter of the Vanderbilt Bill Wilkerson Center and a former member of its board of directors, died Nov. 18. She was 88.
Nov. 14, 2019—Rakesh Chandra, MD, has been appointed editor-in-chief of Ear, Nose & Throat Journal, a monthly publication that highlights scientific research relevant to clinical care in the field of otolaryngology.
Oct. 10, 2019—Sarah Sexton Walters, NP, has been appointed to the board of directors for HOSA, an international student organization dedicated to empowering future health professionals to become leaders in the global health community.
Jun. 26, 2019—Last week, the Vanderbilt Bill Wilkerson Center co-hosted the 8th Quadrennial Internal Conference on Vestibular Schwannoma and Other CPA (cerebellopontine angle) Tumors in partnership with Mayo Clinic.
Jun. 13, 2019—Armed with $1.2 million in funding from the National Heart, Lung and Blood Institute (NHLBI), researchers at Vanderbilt University Medical Center are searching to understand the cause of a rare airway disease in hopes of developing better treatments.
May. 22, 2019—Gaelyn Garrett, MD, MMHC, was recently inducted as the first female president of the American Laryngological, Rhinological and Otological Society.
Apr. 4, 2019—Early diagnosis of head and neck cancer greatly increases odds of survival, but its symptoms can be subtle or mimic viral infections, so Vanderbilt Health offers a free screening annually.
Feb. 21, 2019—An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.